SB-T-101141, CAS [[186348-05-0]] Preis auf Anfrage

Artikelnummer: TGM-T211012
Artikelname: SB-T-101141, CAS [[186348-05-0]] Preis auf Anfrage
Artikelnummer: TGM-T211012
Hersteller Artikelnummer: T211012
Alternativnummer: TGM-T211012-10MG,TGM-T211012-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
SB-T-101141 is a novel taxane drug effective in inducing atypical ferroptosis, thereby overcoming resistance of breast cancer to Paclitaxel. It promotes the generation of iron ions, ferrous ions, and reactive oxygen species (ROS). SB-T-101141 stably binds to KHSRP, inhibiting the expression of the iron-dependent CISD1 related to iron homeostasis. It synergistically enhances the activation of the iron-dependent JNK and PERK pathways through KHSRP. SB-T-101141 inhibits breast tumor growth in MCF-7(PR)/MDA-MB-231(PR) or KHSRP knockout MCF-7 xenograft mouse models.
Molekulargewicht: 869.9
CAS Nummer: [186348-05-0]
Formel: C44H55NO17
Target-Kategorie: JNK|||p38 MAPK|||Ferroptosis|||ROS
T211012